About 5,900,000 results
Open links in new tab
  1. Fierce Pharma Biopharma News & Insights

    4 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

  2. Pharmaceuticals News -- ScienceDaily

    Dec 2, 2025 · Research news on the pharmaceutical industry including new drugs and interventions.

  3. Biopharma News | Today's Latest Stories | Reuters

    Dec 12, 2025 · Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to approaching the brain-wasting disease as a system …

  4. Pharma Industry - Latest News, Investigations and Analysis

    The latest news on health and wellness, including the healthcare industry, pharmaceuticals and more.

  5. Biotech and Pharma Industry News | BioPharma Dive

    Dec 11, 2025 · BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma …

  6. Pharma, Biotech and Generics Industry News | The Pharmaletter

    Dec 10, 2025 · Up to date news for the pharmaceutical and biotechnology industries - The Pharma Letter

  7. Pharmaceuticals sector - Financial Times

    Dec 10, 2025 · Comprehensive coverage of the pharmaceuticals industry. The latest news and developments from the world's leading drug companies, including Pfizer, Johnson & Johnson, …

  8. News | PharmExec

    In today’s Pharmaceutical Executive Daily, Eli Lilly reports positive topline Phase III results for retatrutide, the FDA expands Amgen’s Uplizna label into generalized myasthenia gravis …

  9. Pharmaceuticals roundup 2025 | Business | Chemistry World

    1 day ago · Pharmaceuticals roundup 2025 It’s been a turbulent year for the pharmaceutical industry, with US political decisions having broad ramifications both at home and abroad.

  10. Pharma Sector News | PharmaVoice

    2 days ago · Big Pharma needs new products to replenish pipelines and has plenty of money in the coffers, but looming uncertainties could stymie dealmaking again. With great power comes …